Abstract
Clinical studies suggest that chemotherapy is associated with long-term cognitive impairment in some patients. Several underlying mechanisms have been proposed; however, the etiology of chemotherapy-related cognitive dysfunction remains relatively unknown. There is evidence that oligodendrocytes and white matter tracts within the CNS may be particularly vulnerable to chemotherapy-related damage and dysfunction. Auditory brainstem responses (ABRs) have been used to detect and measure functional integrity of myelin in a variety of animal models of autoimmune disorders and demyelinating diseases. Limited evidence suggests that increases in interpeak latencies, associated with disrupted impulse conduction, can be detected in ABRs following 5-fluorouracil administration in mice. It is unknown if similar functional disruptions can be detected following treatment with other chemotherapeutic compounds and the extent to which alterations in ABR signals represent robust and long-lasting impairments associated with chemotherapy-related cognitive impairment. Thus, C57BL/6 J mice were treated every 3rd day for a total of 3 injections with low or high dose cyclophosphamide, or doxorubicin. ABRs of mice were assessed on days 1, 7, 14, 56 and 6 months following completion of chemotherapy administration. There were timing and amplitude differences in the ABRs of the doxorubicin and the high dose cyclophosphamide groups relative to the control animals. However, despite significant toxic effects as assessed by weight loss, the changes in the ABR were transient.
Similar content being viewed by others
Data availability
The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201. https://doi.org/10.1038/nrc2073
Billiet T, Emsell L, Vandenbulcke M et al (2018) Recovery from chemotherapy-induced white matter changes in young breast cancer survivors? Brain Imaging Behav 12:64–77. https://doi.org/10.1007/s11682-016-9665-8
Bower JE (2014) Cancer-related fatigue—mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 11:597
Briones TL, Woods J (2014) Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapy-related cognitive impairment. Brain Behav Immun 35:23–32. https://doi.org/10.1016/j.bbi.2013.07.175
Briones TL, Woods J (2011) Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications. BMC Neurosci 12:1–13. https://doi.org/10.1186/1471-2202-12-124
Brismar T (1981) Electrical properties of isolated demyelinated rat nerve fibers. Acta Physiol Scand 113:161–166. https://doi.org/10.1111/j.1748-1716.1981.tb06877.x
Burkard R (2006) Calibration of acoustic transients. Brain Res 1091:27–31. https://doi.org/10.1016/j.brainres.2006.02.132
Carpinelli MR, Voss AK, Manning MG et al (2014) A new mouse model of Canavan leukodystrophy displays hearing impairment due to central nervous system dysmyelination. Dis Model Mech 7(6):649–657. https://doi.org/10.1242/dmm.014605
Christie LA, Acharya MM, Parihar VK et al (2012) Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res 18:1954–1965. https://doi.org/10.1158/1078-0432.CCR-11-2000
Collins B, MacKenzie J, Tasca GA et al (2014) Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy. J Int Neuropsychol Soc 20:370–379. https://doi.org/10.1017/s1355617713001215
Cragg BG, Thomas PK (1964) Changes in nerve conduction in experimental allergic neuritis. J Neurol Neurosurg Psychiatry 27:106–115. https://doi.org/10.1136/jnnp.27.2.106
Cerulla TN, Navarro Pastor JB, de Chaparrola Osa N (2020) Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy. J Cancer Surv 14:1–19. https://doi.org/10.1007/s11764-020-00870-2
Evenden J (2013) Cognitive impairments and cancer chemotherapy: translational research at a crossroads. Life Sci 93:589–595. https://doi.org/10.1016/j.lfs.2013.03.020
Focan C (1995) Circadian rhythms and cancer chemotherapy. Pharmacol Ther 67:1–52. https://doi.org/10.1016/0163-7258(95)00009-6
Foley JJ, Raffa RB, Walker EA (2008) Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology 199:527–538. https://doi.org/10.1007/s00213-008-1175-y
Fremouw T, Fessler CL, Ferguson RJ, Burguete Y (2012a) Preserved learning and memory in mice following chemotherapy: 5-Fluorouracil and doxorubicin single agent treatment, doxorubicin–cyclophosphamide combination treatment. Behav Brain Res 226:154–162. https://doi.org/10.1016/j.bbr.2011.09.013
Fremouw T, Fessler CL, Ferguson RJ, Burguete Y (2012b) Recent and remote spatial memory in mice treated with cytosine arabinoside. Pharmacol Biochem Behav 100:451–457. https://doi.org/10.1016/j.pbb.2011.10.008
Gandal MJ, Ehrlichman RS, Rudnick ND, Siegel SJ (2008) A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice. Neuroscience 157:95–104. https://doi.org/10.1016/j.neuroscience.2008.08.060
Geraghty AC, Gibson EM, Ghanem RA et al (2019) Loss of adaptive myelination contributes to methotrexate chemotherapy-related cognitive impairment. Neuron 103:250–265. https://doi.org/10.1016/j.neuron.2019.04.032
Han R, Yang YM, Dietrich J et al (2008) Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 7:12.1-12.22
Henry KR (1979) Auditory brainstem volume-conducted responses: origins in the laboratory mouse. J Am Audit Soc 4:173–178
Hunter KP, Willott JF (1987) Aging and the auditory brainstem response in mice with severe or minimal presbycusis. Hear Res 30:207–218. https://doi.org/10.1016/0378-5955(87)90137-7
Janelsins MC, Heckler CE, Peppone LJ et al (2018) Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study. J Clin Oncol 36:3231–3239
Janelsins MC, Roscoe JA, Berg MJ et al (2010) IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest 28:544–553. https://doi.org/10.3109/07357900903405942
Jerger J, Hall J (1980) Effects of age and sex on auditory brainstem response. Arch Otolaryngol 106:387–391. https://doi.org/10.1001/archotol.1980.00790310011003
Keithley EM, Canto C, Zheng QY et al (2004) Age-related hearing loss and the ahl locus in mice. Hear Res 188:21–28. https://doi.org/10.1016/s0378-5955(03)00365-4
Koppelmans V, Breteler MMB, Boogerd W et al (2012) Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 30:1080–1086. https://doi.org/10.1200/JCO.2011.37.0189
Lamas V, Alvarado JC, Carro J, Merchán MA (2013) Long-Term Evolution of Brainstem Electrical Evoked Responses to Sound after Restricted Ablation of the Auditory Cortex. PLoS ONE 8(9):e73585. https://doi.org/10.1371/journal.pone.0073585
Land R, Burghard A, Kral A (2016) The contribution of inferior colliculus activit to the auditory brainstem response in mice. Hear Res 341:109–118. https://doi.org/10.1016/j.heares.2016.08.008
Liu L, Mills PJ, Rissling M et al (2012) Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun 26:706–713. https://doi.org/10.1016/j.bbi.2012.02.001
Long JM, Lee GD, Kelley-Bell B et al (2011) Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats. Pharmacol Biochem Behav 100:205–211. https://doi.org/10.1016/j.pbb.2011.08.012
Long P, Wan G, Roberts MT, Corfas G (2018) Myelin development, plasticity, and pathology in the auditory system. Develop Neurobiol. 78:80–92
MacLeod JE, DeLeo JA, Hickey WF et al (2007) Cancer chemotherapy impairs contextual but not cue-specific fear memory. Behav Brain Res 181:168–172. https://doi.org/10.1016/j.bbr.2007.04.003
Martin BA, Tremblay KL, Stapells DR (2007) Principles and applications of cortical auditory evoked potentials. In: Eggermont JJ, Don M (eds) Burkard RF. Auditory Evoked Potentials: Basic Principles and Clinical Applications. Lippincott Williams & Wilkins, Philadelphia, pp 482–507
Matsos A, Johnston IN (2019) Chemotherapy-induced cognitive impairments: a systematic review of the animal literature. Neurosci Biobehav Rev 102:382–399. https://doi.org/10.1016/j.neubiorev.2019.05.001
Matsos A, Loomes M, Zhou I et al (2017) Chemotherapy-induced cognitive impairments: white matter pathologies. Cancer Treat Rev 61:6–14. https://doi.org/10.1016/j.ctrv.2017.09.010
McLeary F, Davis A, Rudrawar S et al (2019) Mechanisms underlying select chemotherapeutic-agent-induced neuroinflammation and subsequent neurodegeneration. Eur J Pharmacol 842:49–56. https://doi.org/10.1016/j.ejphar.2018.09.034
Melcher JR, Kiang NY (1996) Generators of the brainstem auditory evoked potential in cat. III: Identified cell populations. Hear Res 93(1–2):52–71. https://doi.org/10.1016/0378-5955(95)00200-6. PMID: 8735068
Miller KD, Nogueira L, Mariotto AB et al (2019) Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 69:363–385
Naito R, Murofushi T, Mizutani M, Kaga K (1999) Auditory brainstem responses, electrocochleograms, and cochlear microphonics in the myelin deficient mutant hamster ‘bt.’ Hear Res 136:44–48. https://doi.org/10.1016/S0378-5955(99)00107-0
Ogier M, Andéol G, Sagui E, Dal Bo G (2020) How to detect and track chronic neurologic sequelae of COVID-19? Use of auditory brainstem responses and neuroimaging for long-term patient follow-up. Brain Behav Immunity-Health 5:100081. https://doi.org/10.1016/j.bbih.2020.100081
Parham K, Sun XM, Kim DO (2001) Noninvasive assessment of auditory function in mice: Auditory brainstem response and distortion product otoacoustic emissions. In: Willott JF (ed) Handbook of Mouse Auditory Research: From Behavior to Molecular Biology. CRC Press, New York, pp 37–58
Raffa RB, Tallarida RJ (2010) Chemo fog: cancer chemotherapy-related cognitive impairment. Preface. Adv Exp Med Biol 678:vii-viii. PMID: 20737998
Reiriz AB, Reolon GK, Preissler T et al (2006) Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice. Clin Cancer Res 12:5000–5001. https://doi.org/10.1158/1078-0432.CCR-06-0138
Ren X, Boriero D, Chaiswing L et al (2019) Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors. Biochimica Et Biophy Acta Mole Basis Dis 1865:1088–1097. https://doi.org/10.1016/j.bbadis.2019.02.007
Roncagliolo M, Benítez J, Eguibar JR (2000) Progressive deterioration of central components of auditory brainstem responses during postnatal development of the myelin mutant taiep rat. Audiol Neurotol 5:267–275. https://doi.org/10.1159/000013891
Seigers R, Fardell JE (2011) Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev 35:729–741. https://doi.org/10.1016/j.neubiorev.2010.09.006
Shah SN, Salamy A (1980) Auditory-evoked far-field potentials in myelin deficient mutant quaking mice. Neuroscience 5:2321–2323. https://doi.org/10.1016/0306-4522(80)90148-7
Vardy J, Rourke S, Tannock IF (2007) Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 25:2455–2463. https://doi.org/10.1200/jco.2006.08.1604
Wan G (2017) Corfas G (2017) Transient auditory nerve demyelination as a new mechanism for hidden hearing loss. Nat Commun 17(8):14487. https://doi.org/10.1038/ncomms14487
Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703–708. https://doi.org/10.1016/s1470-2045(10)70294-1
Weiner HL, Cohen JA (2002) Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects. Mult Scler J 8:142–154. https://doi.org/10.1191/1352458502ms790oa
Weiss B (2010) Evaluation of multiple neurotoxic outcomes in cancer chemotherapy. In: Raffa RB, Tallarida RJ (eds) Chemo fog: cancer chemotherapy-related cognitive impairment, vol 678. Springer & Landes, New York, p 96
Weymann KB, Wood LJ, Zhu X, Marks DL (2014) A role for orexin in cytotoxic chemotherapy-induced fatigue. Brain Behav Immun 37:84–94
Winocur G, Henkelman M, Wojtowicz JM et al (2012) The effects of chemotherapy on cognitive function in a mouse model: a prospective study. Clin Cancer Res 18:3112–3121. https://doi.org/10.1158/1078-0432.CCR-12-0060
Winocur G, Johnston I, Castel H (2018) Chemotherapy and cognition: international cognition and cancer task force recommendations for harmonising preclinical research. Cancer Treat Rev 69:72–83. https://doi.org/10.1016/j.ctrv.2018.05.017
Wood LJ, Nail LM, Perrin NA et al (2006) The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior–like symptoms in a mouse model of cancer chemotherapy–related symptoms. Biol Res Nursing 8:157–169
Xing Y, Samuvel DJ, Stevens SM et al (2012) Age-related changes of myelin basic protein in mouse and human auditory nerve. PLoS ONE 7:e34500. https://doi.org/10.1371/journal.pone.0034500
Zheng QY, Johnson KR, Erway LC (1999) Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 130:94–107. https://doi.org/10.1016/S0378-5955(99)00003-9
Zhou R, Abbas PJ, Assouline JG (1995) Electrically evoked auditory brainstem response in peripherally myelin-deficient mice. Hear Res 88:98–106. https://doi.org/10.1016/0378-5955(95)00105-D
Funding
This study was funded in part by DOD grant (W81XWH-10–1-0692).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interests to declare that are relevant to the content of this article.
Additional information
Communicated by Bill J Yates.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hennings, M., Fremouw, T. The effect of doxorubicin or cyclophosphamide treatment on auditory brainstem response in mice. Exp Brain Res 240, 2907–2921 (2022). https://doi.org/10.1007/s00221-022-06463-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00221-022-06463-y